2 Cannabis Stocks to Buy and Hold for Decades

Cannabis stocks are volatile, but the industry could double or triple in size over the next few years. Find out why Canopy Growth Corp (TSX:WEED)(NYSE:CGC) and another small competitors are your best bets.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks went gangbusters last year. If you were invested in many of the stocks that doubled or tripled in value, congratulations. This year, however, pot stocks haven’t performed as well, with some of them down 20% to 60%.

Despite the volatility, one thing is certain: the cannabis industry will continue to grow over the next decade and beyond. According to one of the top marijuana analysts, the U.S. industry alone will be worth $80 billion by 2030.

The current sales figures are but a fraction of that number. Last year, Canada became the first western country to legalize recreational pot. The resulting domino effect could add billions of market value to the industry every year.

Although pot stocks have been volatile, that shouldn’t stop you from investing for the long term. It’s not necessary to buy at the absolute bottom to make a bunch of money.

In fact, those who wait for the perfect moment often miss the train entirely. If you want to ride the cannabis boom for years to come, here are your best bets.

Tobacco 2.0

There’s one major risk every cannabis investor will face long-term: commoditzation. Today, most growers are still scrambling to ramp production. Over the next 12 to 18 months, millions of pounds of weed could flood the market.

Regulation is keeping competition at bay, but over time, prices will fall, reducing the value of grower’s crop. There are two ways to battle complete commoditzation: pricing power and cost advantages.

When it comes to cost, larger players will likely win. That’s the story for nearly any commodity in history—if you have the scale, you’re likely a low-cost producer.

Armed with a $12 billion market cap, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is already significantly ahead of the competition in amassing scale.

In terms of pricing power, differentiation and branding will be key. If you have the largest marketing budget, odds are you’ll be able to build a moat around your product line-up. Even if smaller players succeed, you’ll have the capital to acquire what they’ve built. If the tobacco industry is any indication, big will be better when it comes to pot. Canopy Growth looks set to capitalize on its early lead.

Hedge your bets

While the cannabis industry may consolidate over time, accruing big advantages to the largest competitors, that doesn’t mean small players don’t have room to run. Green Organic Dutchman Holdings Ltd (TSX:TGOD) is a perfect example.

Over time, don’t be surprised if this stock is eventually acquired by a larger peer, most likely at a large premium to today’s trading price.

What makes Green Organic so special is that 100% of its production is grown in accordance to organic agriculture principles. It’s one of the only growers focused on this niche. As cannabis production becomes commoditized, and prices fall, Green Organic has an opportunity to sell a differentiated product at higher prices.

After last year’s cannabis hype collapsed, investors abandoned Green Organic stock in favor of its larger peers. The company’s market valuation is down to $800 million despite analysts believing the company will hit $225 million in sales next year.

By 2021, this hyper-growth company could be trading at just two times sales. It’ll take a couple years to play out, but this stock has clear multi-bagger potential.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »